In December, 2015, Dow Chemicals Co. and DuPont announced a proposed merger between their two companies. Under the proposed deal, and with the approval of stockholders and regulators, the two agro/chemical giants will merger their companies in 2016 to create DowDuPont, with an estimated $130 billion value. Within 18-24 months of closing, DowDuPont will be split into three independent, publicly traded companies .
The proposed “merger of equals” is structured to share power equally between Dow and DuPont and its leadership in the new company. Dow and DuPont stockholders will each own roughly half of DowDuPont. There will be 16 members on the new DowDuPont board of directors: 8 from each company. The roles of Chairman and CEO will be split with Andrew Liveris (Dow) serving as Chairman and Edward Breen (DuPont) as CEO.
Questions of equality and perceived power imbalance arise when we examine the relationships between (1) corporate boards and activist investors; (2) various shareholders (hedge funds vs. institutional investors vs. retail investors, etc.), and (3) possibly, CEO’s.
Let’s tackle the first (and tangentially the second) imbalance by talking about hedge funds. Last year, Trian hedge fund targeted DuPont in a very expensive, public and close proxy
